 | • レポートコード：QY2112C03883 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はメトロニダゾール注射の世界市場の現状について調査・分析し、2027年までの市場を予測しました。メトロニダゾール注射の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（500mg/100mL、50mg/10mL）、用途別市場規模（成人用、小児用、高齢者用）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・メトロニダゾール注射の世界市場概要 ・メーカー別の競争状況、市場シェア ・メトロニダゾール注射の種類別市場規模：500mg/100mL、50mg/10mL ・メトロニダゾール注射の用途別市場規模：成人用、小児用、高齢者用 ・北米のメトロニダゾール注射市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのメトロニダゾール注射市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのメトロニダゾール注射市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のメトロニダゾール注射市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのメトロニダゾール注射市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Pfizer、B. Braun Medical Inc、Sanofi-Aventis Canada Inc、Baxter、JB Chemicals and Pharmaceuticals、Qatar Pharma、Unique Pharmaceuticals、Sagent Pharmaceuticals、AdvaCare Pharma ・メトロニダゾール注射のバリューチェーン・販売チャネル分析 ・メトロニダゾール注射の世界市場動向 |
Metronidazole Injection is a sterile, parenteral dosage form of metronidazole in water. Metronidazole is classified as a synthetic antibacterial and antiprotozoal agent and is administered by the intravenous route. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Metronidazole Injection and other antibacterial drugs, Metronidazole Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Metronidazole injection is used to treat certain skin, blood, bone, joint, gynecologic, and abdominal (stomach area) infections caused by bacteria. It is also used to treat endocarditis (infection of the heart lining and valves), meningitis (infection of the membranes that surround the brain and spinal cord), and certain respiratory infections, including pneumonia. Metronidazole injection is also to prevent infection when used before, during, and after colorectal surgery. Metronidazole injection is in a class of medications called antibacterials. It works by killing bacteria and protozoa that cause infection.
Market Analysis and Insights: Global Metronidazole Injection Market
The global Metronidazole Injection market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Metronidazole Injection Scope and Segment
Metronidazole Injection market is segmented by Dosage Form & Strength Type, and by Application. Players, stakeholders, and other participants in the global Metronidazole Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Dosage Form & Strength Type and by Application for the period 2016-2027.
Segment by Dosage Form & Strength Type
500mg/100mL
50mg/10mL
Segment by Application
Adult Use
Pediatric Use
Geriatric Use
By Company
Pfizer
B. Braun Medical Inc
Sanofi-Aventis Canada Inc
Baxter
JB Chemicals and Pharmaceuticals
Qatar Pharma
Unique Pharmaceuticals
Sagent Pharmaceuticals
AdvaCare Pharma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Metronidazole Injection Product Introduction
1.2 Market by Dosage Form & Strength Type
1.2.1 Global Metronidazole Injection Market Size Growth Rate by Dosage Form & Strength Type
1.2.2 500mg/100mL
1.2.3 50mg/10mL
1.3 Market by Application
1.3.1 Global Metronidazole Injection Market Size Growth Rate by Application
1.3.2 Adult Use
1.3.3 Pediatric Use
1.3.4 Geriatric Use
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Metronidazole Injection Sales Estimates and Forecasts 2016-2027
2.2 Global Metronidazole Injection Revenue Estimates and Forecasts 2016-2027
2.3 Global Metronidazole Injection Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Metronidazole Injection Regions by Sales
2.4.1 Global Top Metronidazole Injection Regions by Sales (2016-2021)
2.4.2 Global Top Metronidazole Injection Regions by Sales (2022-2027)
2.5 Global Top Metronidazole Injection Regions by Revenue
2.5.1 Global Top Metronidazole Injection Regions by Revenue (2016-2021)
2.5.2 Global Top Metronidazole Injection Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Metronidazole Injection Sales by Manufacturers
3.1.1 Global Top Metronidazole Injection Manufacturers by Sales (2016-2021)
3.1.2 Global Top Metronidazole Injection Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Metronidazole Injection Sales in 2020
3.2 Global Metronidazole Injection Revenue by Manufacturers
3.2.1 Global Top Metronidazole Injection Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Metronidazole Injection Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Metronidazole Injection Revenue in 2020
3.3 Global Metronidazole Injection Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Metronidazole Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Metronidazole Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Metronidazole Injection Sales by Dosage Form & Strength Type
4.1.1 Global Metronidazole Injection Historical Sales by Dosage Form & Strength Type (2016-2021)
4.1.2 Global Metronidazole Injection Forecasted Sales by Dosage Form & Strength Type (2022-2027)
4.1.3 Global Metronidazole Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
4.2 Global Metronidazole Injection Revenue by Dosage Form & Strength Type
4.2.1 Global Metronidazole Injection Historical Revenue by Dosage Form & Strength Type (2016-2021)
4.2.2 Global Metronidazole Injection Forecasted Revenue by Dosage Form & Strength Type (2022-2027)
4.2.3 Global Metronidazole Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
4.3 Global Metronidazole Injection Price by Dosage Form & Strength Type
4.3.1 Global Metronidazole Injection Price by Dosage Form & Strength Type (2016-2021)
4.3.2 Global Metronidazole Injection Price Forecast by Dosage Form & Strength Type (2022-2027)
5 Market Size by Application
5.1 Global Metronidazole Injection Sales by Application
5.1.1 Global Metronidazole Injection Historical Sales by Application (2016-2021)
5.1.2 Global Metronidazole Injection Forecasted Sales by Application (2022-2027)
5.1.3 Global Metronidazole Injection Sales Market Share by Application (2016-2027)
5.2 Global Metronidazole Injection Revenue by Application
5.2.1 Global Metronidazole Injection Historical Revenue by Application (2016-2021)
5.2.2 Global Metronidazole Injection Forecasted Revenue by Application (2022-2027)
5.2.3 Global Metronidazole Injection Revenue Market Share by Application (2016-2027)
5.3 Global Metronidazole Injection Price by Application
5.3.1 Global Metronidazole Injection Price by Application (2016-2021)
5.3.2 Global Metronidazole Injection Price Forecast by Application (2022-2027)
6 North America
6.1 North America Metronidazole Injection Market Size by Dosage Form & Strength Type
6.1.1 North America Metronidazole Injection Sales by Dosage Form & Strength Type (2016-2027)
6.1.2 North America Metronidazole Injection Revenue by Dosage Form & Strength Type (2016-2027)
6.2 North America Metronidazole Injection Market Size by Application
6.2.1 North America Metronidazole Injection Sales by Application (2016-2027)
6.2.2 North America Metronidazole Injection Revenue by Application (2016-2027)
6.3 North America Metronidazole Injection Market Size by Country
6.3.1 North America Metronidazole Injection Sales by Country (2016-2027)
6.3.2 North America Metronidazole Injection Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Metronidazole Injection Market Size by Dosage Form & Strength Type
7.1.1 Europe Metronidazole Injection Sales by Dosage Form & Strength Type (2016-2027)
7.1.2 Europe Metronidazole Injection Revenue by Dosage Form & Strength Type (2016-2027)
7.2 Europe Metronidazole Injection Market Size by Application
7.2.1 Europe Metronidazole Injection Sales by Application (2016-2027)
7.2.2 Europe Metronidazole Injection Revenue by Application (2016-2027)
7.3 Europe Metronidazole Injection Market Size by Country
7.3.1 Europe Metronidazole Injection Sales by Country (2016-2027)
7.3.2 Europe Metronidazole Injection Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Metronidazole Injection Market Size by Dosage Form & Strength Type
8.1.1 Asia Pacific Metronidazole Injection Sales by Dosage Form & Strength Type (2016-2027)
8.1.2 Asia Pacific Metronidazole Injection Revenue by Dosage Form & Strength Type (2016-2027)
8.2 Asia Pacific Metronidazole Injection Market Size by Application
8.2.1 Asia Pacific Metronidazole Injection Sales by Application (2016-2027)
8.2.2 Asia Pacific Metronidazole Injection Revenue by Application (2016-2027)
8.3 Asia Pacific Metronidazole Injection Market Size by Region
8.3.1 Asia Pacific Metronidazole Injection Sales by Region (2016-2027)
8.3.2 Asia Pacific Metronidazole Injection Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Metronidazole Injection Market Size by Dosage Form & Strength Type
9.1.1 Latin America Metronidazole Injection Sales by Dosage Form & Strength Type (2016-2027)
9.1.2 Latin America Metronidazole Injection Revenue by Dosage Form & Strength Type (2016-2027)
9.2 Latin America Metronidazole Injection Market Size by Application
9.2.1 Latin America Metronidazole Injection Sales by Application (2016-2027)
9.2.2 Latin America Metronidazole Injection Revenue by Application (2016-2027)
9.3 Latin America Metronidazole Injection Market Size by Country
9.3.1 Latin America Metronidazole Injection Sales by Country (2016-2027)
9.3.2 Latin America Metronidazole Injection Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Metronidazole Injection Market Size by Dosage Form & Strength Type
10.1.1 Middle East and Africa Metronidazole Injection Sales by Dosage Form & Strength Type (2016-2027)
10.1.2 Middle East and Africa Metronidazole Injection Revenue by Dosage Form & Strength Type (2016-2027)
10.2 Middle East and Africa Metronidazole Injection Market Size by Application
10.2.1 Middle East and Africa Metronidazole Injection Sales by Application (2016-2027)
10.2.2 Middle East and Africa Metronidazole Injection Revenue by Application (2016-2027)
10.3 Middle East and Africa Metronidazole Injection Market Size by Country
10.3.1 Middle East and Africa Metronidazole Injection Sales by Country (2016-2027)
10.3.2 Middle East and Africa Metronidazole Injection Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Metronidazole Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Pfizer Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 B. Braun Medical Inc
11.2.1 B. Braun Medical Inc Corporation Information
11.2.2 B. Braun Medical Inc Overview
11.2.3 B. Braun Medical Inc Metronidazole Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 B. Braun Medical Inc Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 B. Braun Medical Inc Recent Developments
11.3 Sanofi-Aventis Canada Inc
11.3.1 Sanofi-Aventis Canada Inc Corporation Information
11.3.2 Sanofi-Aventis Canada Inc Overview
11.3.3 Sanofi-Aventis Canada Inc Metronidazole Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Sanofi-Aventis Canada Inc Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi-Aventis Canada Inc Recent Developments
11.4 Baxter
11.4.1 Baxter Corporation Information
11.4.2 Baxter Overview
11.4.3 Baxter Metronidazole Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Baxter Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Baxter Recent Developments
11.5 JB Chemicals and Pharmaceuticals
11.5.1 JB Chemicals and Pharmaceuticals Corporation Information
11.5.2 JB Chemicals and Pharmaceuticals Overview
11.5.3 JB Chemicals and Pharmaceuticals Metronidazole Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 JB Chemicals and Pharmaceuticals Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 JB Chemicals and Pharmaceuticals Recent Developments
11.6 Qatar Pharma
11.6.1 Qatar Pharma Corporation Information
11.6.2 Qatar Pharma Overview
11.6.3 Qatar Pharma Metronidazole Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Qatar Pharma Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Qatar Pharma Recent Developments
11.7 Unique Pharmaceuticals
11.7.1 Unique Pharmaceuticals Corporation Information
11.7.2 Unique Pharmaceuticals Overview
11.7.3 Unique Pharmaceuticals Metronidazole Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Unique Pharmaceuticals Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Unique Pharmaceuticals Recent Developments
11.8 Sagent Pharmaceuticals
11.8.1 Sagent Pharmaceuticals Corporation Information
11.8.2 Sagent Pharmaceuticals Overview
11.8.3 Sagent Pharmaceuticals Metronidazole Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Sagent Pharmaceuticals Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sagent Pharmaceuticals Recent Developments
11.9 AdvaCare Pharma
11.9.1 AdvaCare Pharma Corporation Information
11.9.2 AdvaCare Pharma Overview
11.9.3 AdvaCare Pharma Metronidazole Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 AdvaCare Pharma Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AdvaCare Pharma Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Metronidazole Injection Value Chain Analysis
12.2 Metronidazole Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Metronidazole Injection Production Mode & Process
12.4 Metronidazole Injection Sales and Marketing
12.4.1 Metronidazole Injection Sales Channels
12.4.2 Metronidazole Injection Distributors
12.5 Metronidazole Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Metronidazole Injection Industry Trends
13.2 Metronidazole Injection Market Drivers
13.3 Metronidazole Injection Market Challenges
13.4 Metronidazole Injection Market Restraints
14 Key Findings in The Global Metronidazole Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Metronidazole Injection Market Size Growth Rate by Dosage Form & Strength Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 500mg/100mL
Table 3. Major Manufacturers of 50mg/10mL
Table 4. Global Metronidazole Injection Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Metronidazole Injection Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Metronidazole Injection Sales by Region (2016-2021) & (KL)
Table 7. Global Metronidazole Injection Sales Market Share by Region (2016-2021)
Table 8. Global Metronidazole Injection Sales by Region (2022-2027) & (KL)
Table 9. Global Metronidazole Injection Sales Market Share by Region (2022-2027)
Table 10. Global Metronidazole Injection Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Metronidazole Injection Revenue Market Share by Region (2016-2021)
Table 12. Global Metronidazole Injection Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Metronidazole Injection Revenue Market Share by Region (2022-2027)
Table 14. Global Metronidazole Injection Sales by Manufacturers (2016-2021) & (KL)
Table 15. Global Metronidazole Injection Sales Share by Manufacturers (2016-2021)
Table 16. Global Metronidazole Injection Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Metronidazole Injection Revenue Share by Manufacturers (2016-2021)
Table 18. Metronidazole Injection Price by Manufacturers 2016-2021 (US$/L)
Table 19. Global Metronidazole Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Metronidazole Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metronidazole Injection as of 2020)
Table 21. Metronidazole Injection Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Metronidazole Injection Product Offered
Table 23. Date of Manufacturers Enter into Metronidazole Injection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Metronidazole Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL)
Table 26. Global Metronidazole Injection Sales by Dosage Form & Strength Type (2022-2027) & (KL)
Table 27. Global Metronidazole Injection Sales Share by Dosage Form & Strength Type (2016-2021)
Table 28. Global Metronidazole Injection Sales Share by Dosage Form & Strength Type (2022-2027)
Table 29. Global Metronidazole Injection Revenue by Dosage Form & Strength Type (2016-2021) & (US$ Million)
Table 30. Global Metronidazole Injection Revenue by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 31. Global Metronidazole Injection Revenue Share by Dosage Form & Strength Type (2016-2021)
Table 32. Global Metronidazole Injection Revenue Share by Dosage Form & Strength Type (2022-2027)
Table 33. Metronidazole Injection Price by Dosage Form & Strength Type (2016-2021) & (US$/L)
Table 34. Global Metronidazole Injection Price Forecast by Dosage Form & Strength Type (2022-2027) & (US$/L)
Table 35. Global Metronidazole Injection Sales by Application (2016-2021) & (KL)
Table 36. Global Metronidazole Injection Sales by Application (2022-2027) & (KL)
Table 37. Global Metronidazole Injection Sales Share by Application (2016-2021)
Table 38. Global Metronidazole Injection Sales Share by Application (2022-2027)
Table 39. Global Metronidazole Injection Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Metronidazole Injection Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Metronidazole Injection Revenue Share by Application (2016-2021)
Table 42. Global Metronidazole Injection Revenue Share by Application (2022-2027)
Table 43. Metronidazole Injection Price by Application (2016-2021) & (US$/L)
Table 44. Global Metronidazole Injection Price Forecast by Application (2022-2027) & (US$/L)
Table 45. North America Metronidazole Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL)
Table 46. North America Metronidazole Injection Sales by Dosage Form & Strength Type (2022-2027) & (KL)
Table 47. North America Metronidazole Injection Revenue by Dosage Form & Strength Type (2016-2021) & (US$ Million)
Table 48. North America Metronidazole Injection Revenue by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 49. North America Metronidazole Injection Sales by Application (2016-2021) & (KL)
Table 50. North America Metronidazole Injection Sales by Application (2022-2027) & (KL)
Table 51. North America Metronidazole Injection Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Metronidazole Injection Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Metronidazole Injection Sales by Country (2016-2021) & (KL)
Table 54. North America Metronidazole Injection Sales by Country (2022-2027) & (KL)
Table 55. North America Metronidazole Injection Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Metronidazole Injection Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Metronidazole Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL)
Table 58. Europe Metronidazole Injection Sales by Dosage Form & Strength Type (2022-2027) & (KL)
Table 59. Europe Metronidazole Injection Revenue by Dosage Form & Strength Type (2016-2021) & (US$ Million)
Table 60. Europe Metronidazole Injection Revenue by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 61. Europe Metronidazole Injection Sales by Application (2016-2021) & (KL)
Table 62. Europe Metronidazole Injection Sales by Application (2022-2027) & (KL)
Table 63. Europe Metronidazole Injection Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Metronidazole Injection Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Metronidazole Injection Sales by Country (2016-2021) & (KL)
Table 66. Europe Metronidazole Injection Sales by Country (2022-2027) & (KL)
Table 67. Europe Metronidazole Injection Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Metronidazole Injection Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Metronidazole Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL)
Table 70. Asia Pacific Metronidazole Injection Sales by Dosage Form & Strength Type (2022-2027) & (KL)
Table 71. Asia Pacific Metronidazole Injection Revenue by Dosage Form & Strength Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Metronidazole Injection Revenue by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Metronidazole Injection Sales by Application (2016-2021) & (KL)
Table 74. Asia Pacific Metronidazole Injection Sales by Application (2022-2027) & (KL)
Table 75. Asia Pacific Metronidazole Injection Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Metronidazole Injection Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Metronidazole Injection Sales by Region (2016-2021) & (KL)
Table 78. Asia Pacific Metronidazole Injection Sales by Region (2022-2027) & (KL)
Table 79. Asia Pacific Metronidazole Injection Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Metronidazole Injection Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Metronidazole Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL)
Table 82. Latin America Metronidazole Injection Sales by Dosage Form & Strength Type (2022-2027) & (KL)
Table 83. Latin America Metronidazole Injection Revenue by Dosage Form & Strength Type (2016-2021) & (US$ Million)
Table 84. Latin America Metronidazole Injection Revenue by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 85. Latin America Metronidazole Injection Sales by Application (2016-2021) & (KL)
Table 86. Latin America Metronidazole Injection Sales by Application (2022-2027) & (KL)
Table 87. Latin America Metronidazole Injection Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Metronidazole Injection Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Metronidazole Injection Sales by Country (2016-2021) & (KL)
Table 90. Latin America Metronidazole Injection Sales by Country (2022-2027) & (KL)
Table 91. Latin America Metronidazole Injection Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Metronidazole Injection Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Metronidazole Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL)
Table 94. Middle East and Africa Metronidazole Injection Sales by Dosage Form & Strength Type (2022-2027) & (KL)
Table 95. Middle East and Africa Metronidazole Injection Revenue by Dosage Form & Strength Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Metronidazole Injection Revenue by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Metronidazole Injection Sales by Application (2016-2021) & (KL)
Table 98. Middle East and Africa Metronidazole Injection Sales by Application (2022-2027) & (KL)
Table 99. Middle East and Africa Metronidazole Injection Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Metronidazole Injection Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Metronidazole Injection Sales by Country (2016-2021) & (KL)
Table 102. Middle East and Africa Metronidazole Injection Sales by Country (2022-2027) & (KL)
Table 103. Middle East and Africa Metronidazole Injection Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Metronidazole Injection Revenue by Country (2022-2027) & (US$ Million)
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 108. Pfizer Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Pfizer Recent Developments
Table 110. B. Braun Medical Inc Corporation Information
Table 111. B. Braun Medical Inc Description and Major Businesses
Table 112. B. Braun Medical Inc Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 113. B. Braun Medical Inc Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. B. Braun Medical Inc Recent Developments
Table 115. Sanofi-Aventis Canada Inc Corporation Information
Table 116. Sanofi-Aventis Canada Inc Description and Major Businesses
Table 117. Sanofi-Aventis Canada Inc Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 118. Sanofi-Aventis Canada Inc Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sanofi-Aventis Canada Inc Recent Developments
Table 120. Baxter Corporation Information
Table 121. Baxter Description and Major Businesses
Table 122. Baxter Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 123. Baxter Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Baxter Recent Developments
Table 125. JB Chemicals and Pharmaceuticals Corporation Information
Table 126. JB Chemicals and Pharmaceuticals Description and Major Businesses
Table 127. JB Chemicals and Pharmaceuticals Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 128. JB Chemicals and Pharmaceuticals Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. JB Chemicals and Pharmaceuticals Recent Developments
Table 130. Qatar Pharma Corporation Information
Table 131. Qatar Pharma Description and Major Businesses
Table 132. Qatar Pharma Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 133. Qatar Pharma Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Qatar Pharma Recent Developments
Table 135. Unique Pharmaceuticals Corporation Information
Table 136. Unique Pharmaceuticals Description and Major Businesses
Table 137. Unique Pharmaceuticals Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 138. Unique Pharmaceuticals Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Unique Pharmaceuticals Recent Developments
Table 140. Sagent Pharmaceuticals Corporation Information
Table 141. Sagent Pharmaceuticals Description and Major Businesses
Table 142. Sagent Pharmaceuticals Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 143. Sagent Pharmaceuticals Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Sagent Pharmaceuticals Recent Developments
Table 145. AdvaCare Pharma Corporation Information
Table 146. AdvaCare Pharma Description and Major Businesses
Table 147. AdvaCare Pharma Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 148. AdvaCare Pharma Metronidazole Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. AdvaCare Pharma Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Metronidazole Injection Distributors List
Table 153. Metronidazole Injection Customers List
Table 154. Metronidazole Injection Market Trends
Table 155. Metronidazole Injection Market Drivers
Table 156. Metronidazole Injection Market Challenges
Table 157. Metronidazole Injection Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Metronidazole Injection Product Picture
Figure 2. Global Metronidazole Injection Market Share by Dosage Form & Strength Type in 2020 & 2027
Figure 3. 500mg/100mL Product Picture
Figure 4. 50mg/10mL Product Picture
Figure 5. Global Metronidazole Injection Market Share by Application in 2020 & 2027
Figure 6. Adult Use
Figure 7. Pediatric Use
Figure 8. Geriatric Use
Figure 9. Metronidazole Injection Report Years Considered
Figure 10. Global Metronidazole Injection Sales 2016-2027 (KL)
Figure 11. Global Metronidazole Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Metronidazole Injection Revenue 2016-2027 (US$ Million)
Figure 13. Global Metronidazole Injection Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Metronidazole Injection Sales Market Share by Region (2016-2021)
Figure 15. Global Metronidazole Injection Sales Market Share by Region (2022-2027)
Figure 16. North America Metronidazole Injection Sales YoY (2016-2027) & (KL)
Figure 17. North America Metronidazole Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Metronidazole Injection Sales YoY (2016-2027) & (KL)
Figure 19. Europe Metronidazole Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Metronidazole Injection Sales YoY (2016-2027) & (KL)
Figure 21. Asia-Pacific Metronidazole Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Metronidazole Injection Sales YoY (2016-2027) & (KL)
Figure 23. Latin America Metronidazole Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Metronidazole Injection Sales YoY (2016-2027) & (KL)
Figure 25. Middle East & Africa Metronidazole Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Metronidazole Injection Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Metronidazole Injection Revenue in 2020
Figure 28. Metronidazole Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Metronidazole Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
Figure 30. Global Metronidazole Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
Figure 31. Global Metronidazole Injection Sales Market Share by Application (2016-2027)
Figure 32. Global Metronidazole Injection Revenue Market Share by Application (2016-2027)
Figure 33. North America Metronidazole Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
Figure 34. North America Metronidazole Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
Figure 35. North America Metronidazole Injection Sales Market Share by Application (2016-2027)
Figure 36. North America Metronidazole Injection Revenue Market Share by Application (2016-2027)
Figure 37. North America Metronidazole Injection Sales Share by Country (2016-2027)
Figure 38. North America Metronidazole Injection Revenue Share by Country (2016-2027)
Figure 39. United States Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Metronidazole Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
Figure 42. Europe Metronidazole Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
Figure 43. Europe Metronidazole Injection Sales Market Share by Application (2016-2027)
Figure 44. Europe Metronidazole Injection Revenue Market Share by Application (2016-2027)
Figure 45. Europe Metronidazole Injection Sales Share by Country (2016-2027)
Figure 46. Europe Metronidazole Injection Revenue Share by Country (2016-2027)
Figure 47. Germany Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 48. France Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Metronidazole Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
Figure 53. Asia Pacific Metronidazole Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
Figure 54. Asia Pacific Metronidazole Injection Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Metronidazole Injection Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Metronidazole Injection Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Metronidazole Injection Revenue Share by Region (2016-2027)
Figure 58. China Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 61. India Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Metronidazole Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
Figure 68. Latin America Metronidazole Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
Figure 69. Latin America Metronidazole Injection Sales Market Share by Application (2016-2027)
Figure 70. Latin America Metronidazole Injection Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Metronidazole Injection Sales Share by Country (2016-2027)
Figure 72. Latin America Metronidazole Injection Revenue Share by Country (2016-2027)
Figure 73. Mexico Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 76. Colombia Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Metronidazole Injection Sales Market Share by Dosage Form & Strength Type (2016-2027)
Figure 78. Middle East and Africa Metronidazole Injection Revenue Market Share by Dosage Form & Strength Type (2016-2027)
Figure 79. Middle East and Africa Metronidazole Injection Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Metronidazole Injection Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Metronidazole Injection Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Metronidazole Injection Revenue Share by Country (2016-2027)
Figure 83. Turkey Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Metronidazole Injection Revenue (2016-2027) & (US$ Million)
Figure 86. Metronidazole Injection Value Chain
Figure 87. Metronidazole Injection Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
ペントバルビタールナトリウム注射のグローバル市場インサイト・予測（～2027年） Pentobarbital Sodium Injection is a sterile solution for intravenous or intramuscular injection. Pentobarbital Sodium Injection is a short-acting barbiturate, chemically designated as sodium 5-ethyl-5-(1-methylbutyl) barbiturate. The barbiturates are nonselective central nervous system depressants w…- ミトキサントロン注射のグローバル市場インサイト・予測（～2027年） Mitoxantrone Injection is a chemotherapy drug. It targets fast dividing cells, like cancer cells, and causes these cells to die. This medicine is used to treat acute nonlymphocytic leukemia (ANLL) and advanced prostate cancer. It is also used to treat certain types of multiple sclerosis. Market Anal…
- ニケタミド注射のグローバル市場インサイト・予測（～2027年） Nikezamei injection is indicated for central respiratory depression and respiratory depression caused by various reasons. Market Analysis and Insights: Global Nikethamide Injection Market The global Nikethamide Injection market is valued at US$ million in 2020. The market size will reach US$ million…
- メトロニダゾール錠のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Metronidazole Tablet Market The global Metronidazole Tablet market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Metronidazole Tablet Scope and Segment Metronid…
- メトロニダゾールカプセルのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Metronidazole Capsule Market The global Metronidazole Capsule market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Metronidazole Capsule Scope and Segment Metro…